by Jonathan P. Ling, Olga Pletnikova, Juan C. Troncoso, and Philip C

Slides:



Advertisements
Similar presentations
Supplementary Figure 1. AB Supplementary Figure 1. L1 and Alu retrotransposition assay. A. Schematic of L1 retrotransposition plasmid (L1). ORF1 and ORF2.
Advertisements

Figure 5 ISOX and vorinostat partially restore splicing pattern in DM1 patient-derived fibroblasts. (A) ISOX and vorinostat partially rescue mis-splicing.
Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A by Richard D. Bagnall, Naushin Waseem, Peter M.
A Common Human β Globin Splicing Mutation Modeled in Mice
Volume 20, Issue 5, Pages (August 2017)
Microprocessor Activity Controls Differential miRNA Biogenesis In Vivo
by Nancy D. Borson, Martha Q. Lacy, and Peter J. Wettstein
Volume 64, Issue 6, Pages (June 2016)
by Takashi Kasukabe, Junko Okabe-Kado, and Yoshio Honma
Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Modification of Alternative Splicing of Mcl-1 Pre-mRNA Using Antisense Morpholino Oligonucleotides Induces Apoptosis in Basal Cell Carcinoma Cells  Jeng-Jer.
by Wen-feng Xu, Zhi-wei Xie, Dominic W. Chung, and Earl W. Davie
by Sanjai Sharma, and Alan Lichtenstein
Volume 10, Issue 1, Pages (July 2002)
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
Transcriptional activities of c-MYB and A-MYB fusion proteins.
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Transient Gene Expression by Nonintegrating Lentiviral Vectors
RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters by Pascal Preker, Jesper Nielsen, Susanne Kammler, Søren Lykke-Andersen,
Volume 129, Issue 3, Pages (May 2007)
PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
Generation of Alternative Ultrabithorax Isoforms and Stepwise Removal of a Large Intron by Resplicing at Exon–Exon Junctions  Allyson R Hatton, Vaidyanathan.
Volume 64, Issue 6, Pages (June 2016)
Volume 84, Issue 3, Pages (February 1996)
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination  Konstantina Skourti-Stathaki, Nicholas J.
The Mouse Spo11 Gene Is Required for Meiotic Chromosome Synapsis
Volume 3, Issue 4, Pages (April 2013)
Exon Circularization Requires Canonical Splice Signals
Volume 13, Issue 1, Pages (January 2004)
RBM24 Is a Major Regulator of Muscle-Specific Alternative Splicing
Volume 117, Issue 3, Pages (April 2004)
Diverse abnormalities manifest in RNA
Identification and differential expression of human collagenase-3 mRNA species derived from internal deletion, alternative splicing, and different polyadenylation.
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
Volume 9, Issue 6, Pages (December 1998)
Volume 18, Issue 2, Pages (April 2005)
Volume 20, Issue 5, Pages (August 2017)
Volume 20, Issue 3, Pages (March 1998)
Volume 3, Issue 2, Pages (February 2013)
Volume 1, Issue 3, Pages (September 2013)
Volume 16, Issue 4, Pages (November 2004)
A Presenilin-1 Truncating Mutation Is Present in Two Cases with Autopsy-Confirmed Early-Onset Alzheimer Disease  Carolyn Tysoe, Joanne Whittaker, John.
Volume 10, Issue 7, Pages (February 2015)
Beth Elliott, Christine Richardson, Maria Jasin  Molecular Cell 
Volume 32, Issue 1, Pages (October 2008)
Volume 39, Issue 3, Pages (August 2010)
A Distinct DNA-Methylation Boundary in the 5′- Upstream Sequence of the FMR1 Promoter Binds Nuclear Proteins and Is Lost in Fragile X Syndrome  Anja Naumann,
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Volume 21, Issue 9, Pages (November 2017)
Identification and characterization of a novel KRAS rearrangement in metastatic prostate cancer. Identification and characterization of a novel KRAS rearrangement.
Adamtsl2 targeting strategy and validation of inactivation.
Volume 25, Issue 2, Pages (February 2017)
Assessing the Functional Characteristics of Synonymous and Nonsynonymous Mutation Candidates by Use of Large DNA Constructs  A.M. Eeds, D. Mortlock, R.
Volume 36, Issue 6, Pages (December 2009)
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients  Claudia Provenzano,
by Tim Wang, Kıvanç Birsoy, Nicholas W. Hughes, Kevin M
circRNA prediction, sequence determination, and validation.
Myotonic Dystrophy Molecular Cell
Fig. 1. Generation of WNK3 knockout mice
Promoting in Tandem: The Promoter for Telomere Transposon HeT-A and Implications for the Evolution of Retroviral LTRs  O.N Danilevskaya, I.R Arkhipova,
Fig. 4 p100/TSN enables E2F1 to interact with alternatively spliced transcripts. p100/TSN enables E2F1 to interact with alternatively spliced transcripts.
Fig. 5 E2F1 also interacts with alternatively spliced transcripts from the MECOM gene. E2F1 also interacts with alternatively spliced transcripts from.
Fig. 6 Metarrestin treatment reduces pre-RNA synthesis and Pol I occupancy at rDNA without changing rDNA chromatin states. Metarrestin treatment reduces.
Manfred Schmid, Agnieszka Tudek, Torben Heick Jensen  Cell Reports 
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
Volume 18, Issue 4, Pages (May 2005)
Fig. 4 ID1 is a direct CREB target.
Fig. 2 hTERT induces expression of heat shock protein genes through HSF1 and interacts with Hsp70-1. hTERT induces expression of heat shock protein genes.
Volume 27, Issue 9, Pages e5 (May 2019)
Presentation transcript:

TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD by Jonathan P. Ling, Olga Pletnikova, Juan C. Troncoso, and Philip C. Wong Science Volume 349(6248):650-655 August 7, 2015 Published by AAAS

Fig. 1 Identification of Tdp-43–associated cryptic exons (Mus musculus). Identification of Tdp-43–associated cryptic exons (Mus musculus). (A) iTDPKO cells are depleted of Tdp-43 upon treatment with 4HT. (B) Visualization of the cryptic exon located in Adnp2 (red bar) of chromosome 18 (chr18) (top). Gene annotation is shown below, labeling exons (thick) and introns (thin). RNA-seq reads from iTDPKO untreated (“Control”) and 4HT treated (“Tdp-43 Knockout”) are aligned to the mm9 genome. The cryptic exon (green arrow) is not conserved (vertebrate conservation, bottom). Strand-specific analysis also confirms the incorporation of cryptic exons on the transcribing strand (fig. S11). (C to E) Most cryptic exons have standard 5′ and 3′ splice sites [Adipor2, (C)]. Occasionally, cryptic exons can present as transcriptional start sites [Sptbn4, (C)], polyadenylation sites [Synj2bp, (D)], or exon extensions [Wbscr22, (E)]. (F) Cryptic exons are flanked by UG tandem repeats that exist upstream, downstream, or internally. Jonathan P. Ling et al. Science 2015;349:650-655 Published by AAAS

Fig. 2 Repression of cryptic exons is associated with the prevention of cell death induced by loss of Tdp-43. Repression of cryptic exons is associated with the prevention of cell death induced by loss of Tdp-43. (A) Diagram of the green fluorescent protein, N terminus TDP-43, RAVER1 splicing repressor domain chimeric construct (GTR). (B) Immunoblot using an antibody that recognizes mouse/human N terminus of Tdp-43. (C to F) Whereas iTDPKO cells are not viable when depleted of Tdp-43, GTR1 cells are fully viable. GTR represses a variety of cryptic exons; standard cassette [Adipor2, (C)], polyadenylation [Zfp809, (D)], and exon extensions [Wbscr22, (E)]. However, some cryptic exons are only partially rescued [Synj2bp, (F)]. (G) RNA-seq transcript expression levels for Tdp-43 knockout cells and GTR1 rescue cells were compared with untreated iTDPKO cells. The top 124 down-regulated/up-regulated genes in the Tdp-43 knockout cells were mostly restored to normal levels in the GTR1 rescued cells. Full transcript expression data are provided in the supplementary materials (data table S1). Jonathan P. Ling et al. Science 2015;349:650-655 Published by AAAS

Fig. 3 Identification of TDP-43–associated cryptic exons (Homo sapiens). Identification of TDP-43–associated cryptic exons (Homo sapiens). (A) TDP-43 protein levels are greatly reduced when HeLa cells are treated with TDP-43 siRNA (asterisk indicates nonspecific band). (B) Visualization of the cryptic exon located in EPB41L4A. Zoom-in of gene annotation demonstrates that the cryptic exon (green arrow) resides in a nonconserved region. Strand-specific analysis also verifies the incorporation of cryptic exons on the transcribing strand (fig. S12). (C to F) IRF9 contains a transcriptional start site (C), KRT7 contains an exon extension (D), GPSM2 contains a standard cryptic exon (E), and INSR contains a polyadenylation site (F). (G) UG repeats are also found adjacent to human cryptic exons. Jonathan P. Ling et al. Science 2015;349:650-655 Published by AAAS

Fig. 4 Validation of human cryptic exons and their detection in ALS-FTD brain tissue. Validation of human cryptic exons and their detection in ALS-FTD brain tissue. (A) Diagram of ATG4B reporter construct and potential splicing isoforms. (B) Immunoblots of HeLa transfections under normal or TDP-43–depleted conditions and (C) the associated electrophoretic gel analysis of splicing isoforms were performed in triplicate. Cryptic isoforms B and C only appeared under conditions of TDP-43 depletion and were rescued by the GTR protein. (D) Diagram of RT-PCR detection strategy. Primers were designed to amplify only the cryptic exon splice junction. (E) DNA fragments are detected at 199 base pairs (bp) (GPSM2) and at 215 bp (ATG4B) for all cases that display TDP-43 proteinopathy; control cases do not display these fragments. Full gel images and case demographics are provided in the supplementary materials (fig. S7 and table S5). Cases 1, 7, and 13 are positive for C9ORF72 expansions; the remaining cases are sporadic. MTG, middle temporal gyrus; MC, motor cortex. Jonathan P. Ling et al. Science 2015;349:650-655 Published by AAAS